- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03489408
Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation
Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation - Study ID 5807
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Conventus CAGE™ PH (PH Cage) System Post-Approval Prospective Study (Study) is a multi-center, prospective, post-approval clinical study designed to collect device and procedure experience in everyday clinical practice.
Specifically, the study will provide:
- Device safety and patient outcome data.
- Device usage data.
- Performance data for the implant procedure.
- Publications.
- Early economic benefit data.
Patient Assessments Demographic and general health data will be collected on all patients at the baseline appointment to ensure subjects meet inclusion/exclusion criteria. In addition, to these data, x-rays and adverse event reports related to the implanted device, surgical procedure and/or study data collection methods will be collected.
Patients will be seen at baseline, 2-, 6- and 12-week, 1- and 2-year post op.
Patient participation in this study is voluntary. However, post-implant patient follow-up adds to the medical community's understanding of proximal humerus fracture patient outcomes, as well as the safety and performance of the PH Cage.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Redwood City, California, United States, 94063
- Stanford University Hospital
-
Torrance, California, United States, 90509
- Harbor-UCLA
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- The Johns Hopkins University
-
-
Massachusetts
-
Duxbury, Massachusetts, United States, 02332
- Snug Harbor Orthopedics
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
The following criteria, in accordance with the product labelling (Instructions For Use), should be considered when selecting patients for inclusion in this Study:
- Patient must be of at least legal age of consent according to applicable State Law.
- Patient is able to understand and provide written consent.
- Patient is willing and able to cooperate with post-operative instructions, including follow-up examinations and limitations of strenuous activities involving the injured extremity.
Exclusion Criteria:
- The PH Cage should not be implanted in patients with suspected or known allergies to titanium or nickel.
- Patients with open wound fractures.
- Patients with ipsilateral injures or concomitant operation(s) that will have a material impact on the study. Such injuries/ operations are those that affect general health status or the function of the injured extremity.
- Pregnant patients.
- Patients with current or history of mental illness and/or dementia.
- Patients with current or history of alcoholism and/or chemical substance abuse.
- Patient has a medical condition(s) that precludes cooperation with the rehabilitation regimen.
- Patient has active infection at the operative site or other active systemic infection.
- Patient has a pathologic proximal humerus fracture.
- Patients proximal humerus fracture extends into the diaphysis.
- Patient has associated glenohumeral dislocation.
- Patient has ipsilateral injury or concomitant surgery that will have a material impact on the study, such that the injury/surgery affects the patients' health status or the function of the injured extremity.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary performance patient assessment
Time Frame: Change from Baseline in Constant Murley Score at 2-year post-op
|
Constant Murley Score
|
Change from Baseline in Constant Murley Score at 2-year post-op
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Carrie Hill, Conventus Orthopaedics, Inc.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5807
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Humeral Fractures, Proximal
-
University of Turin, ItalyRecruitingProximal Humeral FracturesItaly
-
Massachusetts General HospitalCompletedProximal Humeral FracturesUnited States
-
Peking University People's HospitalUnknown
-
RWTH Aachen UniversityCompletedProximal Humeral FracturesGermany
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedHumeral Fracture, Proximal
-
Karolinska InstitutetCompleted
-
Herlev HospitalOdense University Hospital; Zealand University Hospital; Aalborg University HospitalUnknownProximal Humeral FracturesDenmark
-
Hospital del MarNot yet recruitingProximal Humeral Fractures, Reverse Shoulder Prostheses, Tuberosities
-
Xiaoxiao ZhouCompletedHumeral Fracture, Proximal | Internal Fixation; Complications, Mechanical, Bones of Limb
-
Oslo University HospitalDiakonhjemmet Hospital; Sykehuset Telemark; Helse Forde; Sykehuset Ostfold; Sykehuset... and other collaboratorsCompletedProximal Humeral Fractures, AO/OTA (2007) Group B2 and C2Norway
Clinical Trials on Conventus Cage™ PH
-
Conventus Orthopaedics, Inc.TerminatedProximal Humeral FractureUnited States
-
Neo Medical SAConfinisCPMActive, not recruitingTrauma | Degenerative Disc Disease | Spinal Stenosis | Spondylolisthesis | Spinal Tumor | Pseudoarthrosis of SpineGermany, Spain
-
Ohio State UniversityRecruitingDegenerative Disc Disease | Spondylolisthesis | Osteophyte | Spinal Canal Stenosis | Bony Growth FormationUnited States
-
University of KentuckyRecruitingSpinal Fusion | Spondylolisthesis | Arthrodesis | Pseudarthrosis | Lumbar FusionUnited States
-
Norwegian University of Science and TechnologyUllevaal University Hospital; University Hospital of North Norway; Haukeland... and other collaboratorsCompleted
-
Medtronic Spinal and BiologicsCompleted
-
Hoffmann-La RocheCompletedHER2-Positive Early Breast CancerUnited States, Finland, Hong Kong, Panama, Portugal, Spain, Mexico, Sweden, Brazil, Serbia, Argentina, Lebanon, Cuba, Qatar, Saudi Arabia, Chile, Jordan
-
Genentech, Inc.CompletedAdvanced Unresectable or Metastatic Solid MalignancyUnited States
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
Hoffmann-La RocheActive, not recruiting